Aglaia Oncology Funds is a financial service company that focuses on investment funds in the research of anti-cancer drugs. The team has decades of experience in cancer research and oncology drug development, committed to selecting and maturing early-stage breakthrough inventions that have the potential to transform cancer treatment. They have invested in various oncology-focused companies through their active funds and have a strong commitment to improving patient outcomes.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions